Evaluation of Pediatric Cardiomyopathy Patients in Pediatric Intensive Care Unit

Şeyda Kesen1, Merve Havan2, Mehmet Ramoğlu3

  • 1Department of Pediatrics, Ankara University Faculty of Medicine, Ankara, Türkiye.

PubMed

Insights

Pediatric cardiomyopathies (CMP) often lead to severe heart failure, requiring intensive care, mechanical ventilation, and advanced circulatory support like ECMO and LVAD. Outcomes remain poor, with over half of patients in this study dying despite aggressive treatments.

Area of Science:

  • Pediatric Cardiology
  • Intensive Care Medicine
  • Cardiovascular Research

Background:

  • Cardiomyopathies (CMP) are a significant cause of end-stage heart failure in children.
  • Understanding the clinical course and treatment needs of pediatric CMP patients in the intensive care setting is crucial.

Purpose of the Study:

  • To evaluate the clinical features, treatments, and outcomes of pediatric patients diagnosed with CMP.
  • To analyze the utilization of intensive care resources and advanced therapies in managing severe pediatric heart failure due to CMP.

Main Methods:

  • Retrospective analysis of 76 pediatric patients diagnosed with CMP admitted to the pediatric intensive care unit (PICU) between 2008 and 2019.
  • Data collected included demographics, CMP type, diagnostic findings, medical and respiratory/circulatory support, cardiac transplantation, and patient outcomes.

Main Results:

  • Dilated cardiomyopathy was the most common type (68.4%).
  • The majority of patients required diuretics (90.8%), inotropes (93.4%), and invasive mechanical ventilation (75%).
  • Advanced support included extracorporeal membrane oxygenation (ECMO) in 43.4%, left ventricular assist device (LVAD) in 15.8%, and biventricular assist device (BiVAD) in 2.6%; 13.2% underwent heart transplantation, with a mortality rate of 52.6%.

Conclusions:

  • Pediatric CMP patients with severe heart failure necessitate intensive care with advanced interventions like mechanical ventilation, ECMO, LVAD, BiVAD, and heart transplantation.
  • Despite aggressive management, mortality remains high, highlighting the critical need for specialized pediatric intensive care and ongoing research into novel therapies.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
480
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
339
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
414
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
314
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
461
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
323